This strain has an A to G point substitution in Cdh23 that is equivalent to the age related hearing loss (Cdh23ahl) mutation and causes mice that are predominantly 129S1/SvImJ to have the age related hearing loss phenotype that is normally found instead in inbred strains bearing the Cdh23ahl mutation, such as C57BL/6J and C57BL/6NJ.
Kenneth Johnson, JAX
Genetic Background | Generation |
---|---|
|
Allele Type | Gene Symbol | Gene Name |
---|---|---|
Targeted (Not Specified) | Cdh23 | cadherin 23 (otocadherin) |
The introduction of this c.753A point mutation in Cdh23 causes age related hearing loss that is more severe than the phenotype of C57BL/6J, a strain that also has the Cdh23 c.753A variant. At 30 days of age, the earliest time point assessed, ABR thresholds show significant deficits at 8 kHz and 16 kHz and complete deafness at 32 kHz. This increased severity is attributable to the different genetic background, including the presence of the 129S allele of the Mahl QTL. The progressive inner and outer cochlear hair cell loss is also more severe than that found in the Cdh23ahl congenic strain that additionally carries the C57BL/6J allele of Mahl (see Stock No. 018926). Genotyping assay details for distinguishing the targeted 753A SNV allele from non-engineered alleles can be found in Johnson et al., 2017, Sci Rep 7:44450.
The sequence of Chromosome 10 from 60,527,162 bp through 60,536,889 bp (GRCm38), which contains the c.753A mutation called age related hearing loss (Cdh23ahl), was cloned from a C57BL/6J-derived BAC, a loxP-flanked PGK-Neo cassette was then inserted 178 bp downstream of the c.753A nucleotide, and homology arms were added to correctly target this sequence to replace the endogenous coding sequence via homologous recombination in 129S1-derived CJ7 ES cells. This resulted in an G to A point mutation, which effectively recapitulates the Cdh23ahl mutation but on a 129S1 background. Founders were bred to 129S/Sv-Tg(Prm-cre)58Og/J to excise the downstream loxP-flanked PGK-Neo cassette and their offspring were bred to 129S1/SvImJ to remove the transgene. Mice heterozygous for this point substitution were intercrossed to homozygosity.
Allele Name | targeted mutation 1.1, Kenneth R Johnson |
---|---|
Allele Type | Targeted (Not Specified) |
Allele Synonym(s) | c.753A; Cdh23c.753A |
Gene Symbol and Name | Cdh23, cadherin 23 (otocadherin) |
Gene Synonym(s) | |
Strain of Origin | 129S1/Sv-Oca2+ Tyr+ Kitl+ |
Chromosome | 10 |
Molecular Note | Chr10: 60,527,162 bp 60,536,889 bp (GRCm38), which contains the c.753A point mutation but is otherwise identical in sequence to the 129S1/SvImJ sequence, was taken from a C57BL/6J-derived BAC, a loxP-flanked PGK-Neo cassette was inserted 178 bp downstream of the c.753 nucleotide, homology arms were added to correctly target this sequence to replace the endogenous coding sequence, resulting in a G to A point substitution with a loxP-flanked PGK-Neo cassette. Subsequent breeding to a cre deleter strain excised the selection cassette and generated this allele. Cochlear transcripts show increased exon skipping as a result of this point mutation, and this is predicted to delete part of the 2nd and 3rd ectodomains. |
When using the 129S/Sv-Cdh23tm1.1Kjn/Kjn mouse strain in a publication, please cite the originating article(s) and include JAX stock #016208 in your Materials and Methods section.
Facility Barrier Level Descriptions
Service/Product | Description | Price |
---|---|---|
Heterozygous for Cdh23<tm1.1Kjn> |
Frozen Mouse Embryo | 129S/Sv-Cdh23<tm1.1Kjn>/Kjn | $2595.00 |
Frozen Mouse Embryo | 129S/Sv-Cdh23<tm1.1Kjn>/Kjn | $2595.00 |
Frozen Mouse Embryo | 129S/Sv-Cdh23<tm1.1Kjn>/Kjn | $3373.50 |
Frozen Mouse Embryo | 129S/Sv-Cdh23<tm1.1Kjn>/Kjn | $3373.50 |
Terms are granted by individual review and stated on the customer invoice(s) and account statement. These transactions are payable in U.S. currency within the granted terms. Payment for services, products, shipping containers, and shipping costs that are rendered are expected within the payment terms indicated on the invoice or stated by contract. Invoices and account balances in arrears of stated terms may result in The Jackson Laboratory pursuing collection activities including but not limited to outside agencies and court filings.
The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project. We do not guarantee breeding performance and therefore suggest that investigators order more than one breeding pair to avoid delays in their research.
What information were you hoping to find through your search?
How easy was it to find what you were looking for?
We may wish to follow up with you. Enter your email if you are happy for us to connect and reachout to you with more questions.
Please Enter a Valid Email Address
Thank you for sharing your feedback! We are working on improving the JAX Mice search. Come back soon for exciting changes.